Work

Comparative Phytochemical Screening of Ethanolic and Aqueous Guava (Psidium guajava L.) Leaf Extracts and Antibacterial Evaluation of the Aqueous Extract against Selected Bacterial Strains

Year: 2026
Type: article
Abstract: Guava (Psidium guajava L.) leaves are a potential source of bioactive secondary metabolites. This study compared the qualitative phytochemical profiles of guava leaf extracts prepared by ethanolic maceration and aqueous decoction and evaluated the antibacterial activity of the aqueous extract against selected bacterial strains. Fresh leaf material was extracted using 96% ethanol or water. Both extracts were screened qualitatively for tannins, saponins, flavonoids, alkaloids, terpenoids, steroids and cardiac glycosides. Antibacterial activity of the aqueous extract was assessed by the disc diffusion method, while the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined by broth microdilution and subculture, respectively. Both extracts gave positive reactions for all seven phytochemical groups. In the disc diffusion assay, the aqueous extract inhibited the tested Gram-positive bacteria, including resistant and wild-type isolates of Staphylococcus aureus and Staphylococcus pseudintermedius, as well as β-haemolytic Streptococcus spp. No inhibition zones were detected against the tested Escherichia coli strains at the concentrations examined. At the highest concentration tested (11.4 mg/mL), the largest inhibition zone was observed against β-haemolytic Streptococcus spp. (21.0 ± 2.0 mm). The MIC was reported as 6.8 mg/mL for all tested strains. The MBC was 6.8 mg/mL for the resistant S. pseudintermedius isolate, whereas it was greater than 11.4 mg/mL for the other strains evaluated. These findings provide preliminary evidence that guava leaf extracts contain several detectable phytochemical groups and that the aqueous extract exhibits in vitro activity against the tested Gram-positive bacteria. Further quantitative phytochemical analysis, confirmation of active constituents, and broader antibacterial and safety studies are required.
Author: Rinky Kumari
Language: English
Subfield: Pharmacology
Open Access status: green
OpenAlex ID: W7234530249
FWCI:
Cites:
Cited by:
Related to: 10